Dermapharm Holding SE (DMPHF)
48.60
0.00 (0.00%)
USD |
OTCM |
May 08, 16:00
Dermapharm Total Liabilities (Quarterly) : 1.765B for Dec. 31, 2025
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Bayer AG | 99.29B |
| Merck KGaA | 27.53B |
| AstraZeneca PLC | 66.63B |
| ANI Pharmaceuticals, Inc. | 859.67M |
| Corcept Therapeutics, Inc. | 176.89M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 2.589B |
| Shareholders Equity (Quarterly) | 815.51M |
| Debt to Equity Ratio | 1.515 |
| Current Ratio | 2.050 |
| Net Debt Paydown Yield | -0.86% |